BMB Reports
Scope & Guideline
Exploring the Depths of Biochemical Discovery
Introduction
Aims and Scopes
- Genome Editing Technologies:
BMB Reports extensively covers advancements in genome editing, particularly through CRISPR/Cas technologies, highlighting innovative applications in various organisms and therapeutic contexts. - Cancer Biology and Therapy:
The journal addresses critical aspects of cancer research, including tumor biology, immune evasion, and therapeutic strategies, with a focus on molecular and cellular mechanisms that inform treatment approaches. - Stem Cell Research and Regenerative Medicine:
Research on stem cells, including their differentiation, applications in regenerative medicine, and therapeutic potential, is a core area of focus, reflecting the journal's commitment to advancing this field. - Metabolism and Disease:
BMB Reports explores the link between metabolism and disease, including studies on metabolic reprogramming in cancer, diabetes, and neurodegenerative diseases, integrating molecular insights into broader health implications. - Immunology and Inflammation:
The journal publishes research on immune responses, inflammatory processes, and the role of immune cells in various diseases, showcasing the interplay between immune mechanisms and disease pathology. - Epigenetics and Gene Regulation:
Epigenetic modifications and their roles in gene regulation, development, and disease are prominently featured, highlighting the complexity of gene expression control in various biological contexts.
Trending and Emerging
- CRISPR and Genome Editing Innovations:
The surge in publications focusing on novel CRISPR applications, including base editing and epigenome editing, reflects a growing interest in refining and expanding genome editing technologies for therapeutic purposes. - Cancer Immunotherapy Advances:
Research on immunotherapy, particularly involving immune checkpoint inhibitors and CAR T-cell therapies, is increasingly prominent, showcasing the journal's commitment to addressing cancer treatment challenges. - Microbiome Research:
Emerging studies linking the microbiome to various diseases, including cancer and metabolic disorders, indicate a trend towards understanding host-microbiome interactions and their therapeutic implications. - Neurobiology and Neurodegenerative Diseases:
There is a noticeable increase in research focused on neurodegenerative diseases, with studies exploring molecular mechanisms and potential therapeutic interventions, reflecting a growing interest in brain health. - Single-Cell and Multi-Omics Approaches:
The adoption of single-cell sequencing and multi-omics technologies is trending, as researchers seek to unravel complex biological systems at unprecedented resolution, emphasizing the journal's alignment with cutting-edge methodologies.
Declining or Waning
- Traditional Genetic Engineering Techniques:
While genome editing remains a vital area, the focus on traditional genetic engineering methods seems to be waning as CRISPR and other advanced techniques dominate the narrative. - Basic Virology Studies:
Research centered solely on basic virology, without integration into broader molecular or therapeutic contexts, appears to be less prevalent, possibly due to the increased emphasis on translational research. - Plant Biotechnology:
Although plant biotechnology is still relevant, its prominence has decreased in favor of more applied and translational approaches in mammalian systems, reflecting a shift towards human health applications.
Similar Journals
Cell Death & Disease
Leading the charge in transformative biomedical discoveries.Cell Death & Disease, published by SpringerNature, is a premier open-access journal dedicated to disseminating high-quality research on the mechanisms and implications of cell death, disease pathology, and therapeutic responses. Since its inception in 2010, the journal has quickly established itself within the top tier of academic publishing, achieving a notable impact factor and earning Q1 rankings in several critical categories including Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, Immunology, and Medicine (miscellaneous). With its commitment to open access, Cell Death & Disease ensures that groundbreaking research is available to a global audience, fostering collaboration and advancing knowledge across disciplines. Residing at the forefront of crucial scientific discourse, this journal not only attracts submissions from leading researchers but also significantly influences the fields of molecular biology, immunology, and neurology. By bridging the gap between basic science and clinical applications, it provides vital insights for professionals, academicians, and students alike.
Biology Direct
Unlocking the frontiers of biological research.Biology Direct is a leading open-access journal published by BMC, dedicated to disseminating groundbreaking research in the fields of biological sciences. Since its inception in 2006, the journal has emerged as a pivotal platform for scholars, researchers, and practitioners, providing unrestricted access to high-quality, peer-reviewed articles that cover a wide spectrum of topics, including biochemistry, ecology, and applied mathematics. With an impressive ranking in the first quartile across multiple scientific categories, including Agricultural and Biological Sciences and Biochemistry, Genetics, and Molecular Biology, Biology Direct is recognized for its rigorous standards and impactful contributions within the academic community. The journal's open-access model ensures that research findings reach a global audience, fostering collaboration and innovation. Researchers and students looking to stay ahead in the rapidly evolving biological sciences will find Biology Direct an invaluable resource for knowledge and insight.
Cells
Connecting Scientists to the Latest in Cellular DiscoveriesCells, published by MDPI in Switzerland, is a leading open-access journal that has been disseminating groundbreaking research in the fields of Biochemistry, Genetics, and Molecular Biology since its inception in 2011. With an impressive E-ISSN of 2073-4409, the journal boasts a strong impact factor and ranks in the 84th percentile for Scopus ratings, underscoring its significance in advancing scientific knowledge. As a Q1-ranked journal in both 2023 and 2020, it serves as a premier platform for researchers, professionals, and students eager to explore innovative findings and methodologies. By providing unrestricted access to high-quality research, Cells plays a pivotal role in facilitating collaboration and inspiration within the global scientific community, making it an indispensable resource for anyone interested in cutting-edge discoveries in cellular biology.
BIOSCIENCE REPORTS
Connecting Researchers with Groundbreaking FindingsBIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.
CELL BIOLOGY INTERNATIONAL
Unveiling the Mysteries of Cellular MechanismsCELL BIOLOGY INTERNATIONAL is a prestigious academic journal dedicated to the rapidly evolving field of cell biology, publishing high-quality research aimed at understanding cellular processes and their implications in various biological contexts. Published by Wiley, this journal has established its relevance with an H-Index that reflects its robust citation impact and a commendable Scopus Rank of #111 out of 285 in the field of Biochemistry, Genetics, and Molecular Biology, positioning it in the 61st percentile. Although it operates under a traditional subscription model, its influential insights are crucial for researchers, professionals, and students alike who are seeking cutting-edge developments in cellular mechanisms and their applications in medicine. The journal spans contributions dating back to 1993, providing a rich archive of knowledge that continues to shape the discourse within the scientific community. With a strong category ranking of Q3 in Cell Biology and Q2 in Medicine (miscellaneous) as of 2023, CELL BIOLOGY INTERNATIONAL stands as a reliable platform for disseminating transformative science in the cellular domain.
Cellular Reprogramming
Exploring New Frontiers in Stem Cell ResearchCellular Reprogramming is a prominent academic journal published by MARY ANN LIEBERT, INC, dedicated to advancing the field of cellular biology and biotechnology. With its ISSN 2152-4971 and E-ISSN 2152-4998, this journal provides an innovative platform for researchers and professionals to share groundbreaking research findings on cellular reprogramming, stem cell biology, and regenerative medicine. Established in 2010, and actively publishing until 2024, the journal is recognized for its contributions, evidenced by its categorizations in the Q3 and Q4 quartiles across several related fields, including biotechnology and developmental biology. This peer-reviewed journal not only supports open access to scientific literature but also aims to enhance interdisciplinary collaboration among scientists. With a growing impact in the realms of biochemistry, genetics, and molecular biology, Cellular Reprogramming remains an essential resource for the dissemination of pioneering research that could shape the future of cellular therapies.
CELLULAR AND MOLECULAR BIOLOGY
Advancing the Frontiers of Life SciencesCellular and Molecular Biology is a prominent academic journal published by C M B ASSOC, specializing in the dynamic fields of cellular and molecular biology. Established in 1977, this journal has consistently aimed to disseminate groundbreaking research that contributes to our understanding of biochemical processes, cell dynamics, and molecular mechanisms governing life. With its ISSN 0145-5680 and E-ISSN 1165-158X, the journal plays a vital role in the exchange of innovative ideas, evidenced by its coverage of research from 1977 to 2024. Although currently categorized in the Q4 quartile for major disciplines such as Biochemistry and Cell Biology, it is dedicated to fostering the development of the field by welcoming submissions that challenge the conventional understanding and lead to novel insights. Researchers and academics looking to contribute to or stay updated in the rapidly evolving landscape of molecular biology will find this journal a valuable resource for connecting with a global community of scientists.
CYTOTHERAPY
Leading the Charge in Cell Biology and Immunology.CYTOTHERAPY is a distinguished journal published by Elsevier Science Ltd, focusing on the critical fields of cell therapy, transplantation, and regenerative medicine. Since its inception in 1999, the journal has established itself as a vital resource for researchers and practitioners, contributing significantly to advancements in Cancer Research, Cell Biology, Genetics, Immunology, and Oncology. With an impressive range of Q2 rankings across multiple categories and a remarkable Q1 standing in Transplantation for 2023, CYTOTHERAPY delivers high-impact research that addresses the evolving challenges in these fields. While the journal does not offer open access, it remains a reputable avenue for disseminating pivotal studies and reviews that push the boundaries of cell-based therapies. Researchers, clinicians, and students alike will find CYTOTHERAPY an indispensable platform to stay abreast of the latest discoveries and innovations that are shaping the future of medical science.
Cell and Bioscience
Pioneering Open Access in Bioscience ResearchCell and Bioscience is a prestigious open-access journal published by BMC that has been at the forefront of biochemistry, genetics, and molecular biology since its inception in 2011. With an impressive impact factor, this journal has established itself as a vital resource for researchers and professionals in these rapidly advancing fields, reflecting its high ranking of #29 out of 221 in the Scopus classification and placing it in the 87th percentile. Based in the United Kingdom, Cell and Bioscience aims to foster innovation and dissemination of research findings addressing critical biological questions through rigorous peer-reviewed articles and inter-disciplinary approaches. The journal's open-access model ensures unrestricted access to transformative research, promoting collaboration and knowledge sharing among academics, students, and practitioners worldwide. With a commitment to maintaining excellence in the field, Cell and Bioscience provides an essential platform for those looking to contribute to the evolving landscape of biosciences.
BIOCELL
Innovative Insights into Cellular MechanismsBIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.